FDA inspection
Consolidated Research, Inc.: FDA inspection ending Mar 25, 2026
FDA inspection 1309448 · Official Action Indicated (OAI) · Euclid, OH
Key facts
| Inspection ID | 1309448 |
|---|---|
| Firm | Consolidated Research, Inc. |
| FEI number | 3009770872 |
| Address | 26250 Euclid Ave Ste 709 |
| City | Euclid |
| State | OH |
| ZIP | 44132 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Mar 25, 2026 |
| Classification | Official Action Indicated (OAI) |
| Project area | Postmarket Assurance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data